Synthesis and antibacterial evaluation of bis-thiazolium, bis- imidazolium and bis-triazolium derivatives

Abstract : Given the worldwide spread of bacterial drug resistance, there is an urgent need to develop new compounds that exhibit potent antibacterial activity and that are unimpaired by this phenomenon. Quaternary ammonium compounds have been used for many years as disinfectants, but recent advances have shown that polycationic derivatives exhibit much stronger activity and are less prone to bacterial resistance than commonly used monocationic compounds. In this sense, we prepared three series of new bis‐cationic compounds: bis‐thiazoliums, bis‐imidazoliums, and bis‐1,2,4‐triazoliums. If some compounds of the first series showed fair antibacterial activity, most of those belonging to the two other series were highly potent, with minimum inhibitory concentrations close to 1 μg mL−1. Some of them also exhibited low toxicity toward eukaryotic MRC‐5 lung fibroblasts, and we showed that this toxicity is clearly correlated with clogP. Finally, four selected compounds were found to exhibit a clear bactericidal effect.
Document type :
Journal articles
Complete list of metadatas

Cited literature [23 references]  Display  Hide  Download

https://hal.univ-lorraine.fr/hal-02146002
Contributor : Michel Boisbrun <>
Submitted on : Monday, June 3, 2019 - 3:17:07 PM
Last modification on : Friday, October 18, 2019 - 10:01:38 AM

Files

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : 2019-12-03

Please log in to resquest access to the document

Identifiers

Collections

Citation

Benoît Thomas, Raphael Duval, Stéphane Fontanay, Mihayl Varbanov, Michel Boisbrun. Synthesis and antibacterial evaluation of bis-thiazolium, bis- imidazolium and bis-triazolium derivatives. ChemMedChem, Wiley-VCH Verlag, 2019, 14 (13), pp.1232-1237. ⟨10.1002/cmdc.201900151⟩. ⟨hal-02146002⟩

Share

Metrics

Record views

25